Focal seizures after treatment with fluvastatin in a patient with a history of catastrophic antiphospholipid syndrome

Journal of the Neurological Sciences

Volumn 238, Issue 1-2, 2005, Pages 93-95

  Miesbach, Wolfgang ^a   Chapman, Joab ^b   Scharrer, Inge ^a  

^a GOETHE UNIVERSITY   (Germany)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antiphospholipid antibodies; Catastrophic Antiphospholipid Syndrome; Fluvastatin; Thrombosis

Indexed keywords

FLUINDOSTATIN; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; WARFARIN;

ADULT; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; CASE REPORT; CELL ACTIVATION; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; DISEASE SEVERITY; DRUG SAFETY; ENDOTHELIUM CELL; FEMALE; FOCAL EPILEPSY; FREQUENCY ANALYSIS; GENETIC LINKAGE; HAND; HUMAN; LEG; MOUTH; NERVOUS SYSTEM INJURY; PAIN; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE DRUG DOSE; SUBDURAL HEMATOMA; SYMPTOM; TERMINAL DISEASE; VASCULITIS; VEIN THROMBOSIS;

ADULT; ANTIPHOSPHOLIPID SYNDROME; BLOOD-BRAIN BARRIER; BRAIN; EPILEPSIES, PARTIAL; FATTY ACIDS, MONOUNSATURATED; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDOLES; MAGNETIC RESONANCE IMAGING; SEIZURES;

EID: 27644566561     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.06.008     Document Type: Article

References (20)

1. W. Miesbach, I. Scharrer, and R.A. Asherson Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation Clin Rheum 23 2004 256 261
2. R.A. Asherson, R. Cervera, P.G. de Groot, D. Erkan, M.C. Boffa, and J.C. Piette Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines Lupus 12 2003 530 534
3. D.E. Ferrara, X. Liu, R.G. Espinola, P.L. Meroni, I. Abdukhalaf, and E.N. Harris Inhibition of the thrombogenic and inflammatory properties of antiphospholipid antibodies by fluvastatin in an in vivo animal model Arthritis Rheum 48 2003 3272 3279
4. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH Thromb Haemost 74 1995 1185 1190
5. W.A. Wilson, A.E. Gharavi, T. Koike, M.D. Lockshin, D.W. Branch, and J.C. Piette International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop Arthritis Rheum 42 1999 1309 1311
6. J. Chapman, J.H. Rand, R.L. Brey, S.R. Levine, I. Blatt, and M.A. Khamashta Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies Lupus 12 2003 514 517
7. Y. Shoenfeld, S. Lev, I. Blatt, M. Blank, J. Font, and P. von Landenberg Features associated with epilepsy in the antiphospholipid syndrome J Rheumatol 31 2004 1344 1348
8. S. Franc, S. Dejager, and E. Bruckert A comprehensive description of muscle syndromes associated with lipid-lowering drugs Cardiovasc Drugs Ther 17 2003 459 465
9. J.M. Backes, and P.A. Howard Association of HMG-CoA reductase inhibitors with neuropathy Ann Pharmacother 37 2003 274 278
10. G. Corrao, A. Zambon, L. Bertu, E. Bofferi, O. Leoni, and P. Contiero Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases J Epidemiol Community Health 58 2004 1047 1051
11. P.H. Chong, A. Boskovich, N. Sterkovic, and R.E. Bartt Statin-associated peripheral neuropathy: review of the literature Pharmacotherapy 24 2004 1194 1203
12. Y.A. Rajabally, V. Varakantam, and R.J. Abbott Disorder resembling Guillain-Barre syndrome on initiation of statin therapy Muscle Nerve 30 2004 663 666
13. M. Vecka, E. Tvrzicka, B. Stankova, F. Novak, O. Novakova, and A. Zak Hypolipidemic drugs can change the composition of rat brain lipids Tohoku J Exp Med 204 2004 299 308
14. M. Focking, M. Besselmann, and T. Trapp Statins potentiate caspase-3 activity in immortalized murine neurons Neurosci Lett 355 2004 41 44
15. C. Denoyelle, M. Vasse, M. Korner, Z. Mishal, F. Ganne, and J.P. Vannier Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study Carcinogenesis 22 2001 1139 1148
16. M. Rodbell The complex regulation of receptor-coupled G proteins Adv Enzyme Regul 37 1997 427 435
17. J. Chen, Z.G. Zhang, Y. Li, Y. Wang, L. Wang, and H. Jiang Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke Ann Neurol 53 2003 743 751
18. J. Chen, C. Zhang, H. Jiang, Y. Li, L. Zhang, and A. Robin Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice J Cereb Blood Flow Metab 25 2005 281 290
19. P.L. Meroni, E. Raschi, M. Camera, C. Testoni, F. Nicoletti, and A. Tincani Endothelial activation by aPL. A potential pathogenetic mechanism for the clinical manifestations of the syndrome J Autoimmun 15 2000 237 240
20. R. Collins, J. Armitage, S. Parish, P. Slight, R. Peto Heart Protection Study Collaborative Group Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions Lancet 363 2004 757 767